Thus, active astrocyte dysfunction during hyperglycemia characterised by a decrease in glial fibrillary acidic protein (GFAP) level has been reported to promote neurocognitive dysfunctions (Yang et al., 2018, Kodidela et al., 2020). The gene discussed is GFAP; the disease is Hyperglycemia.